Jiangsu Lianhuan Pharmaceutical Co., Ltd. (SHA:600513)

China flag China · Delayed Price · Currency is CNY
15.92
-0.16 (-1.00%)
Jun 11, 2026, 9:50 AM CST
Market Cap4.59B +76.5%
Revenue (ttm)2.89B +28.1%
Net Income-114.97M
EPS-0.39
Shares Out 285.46M
PE Ration/a
Forward PEn/a
Dividend0.07 (0.43%)
Ex-Dividend DateJun 23, 2025
Volume1,198,900
Open15.88
Previous Close16.08
Day's Range15.72 - 16.09
52-Week Range9.05 - 32.27
Beta-0.17
Analystsn/a
Price Targetn/a
Earnings DateAug 26, 2026

About SHA:600513

Jiangsu Lianhuan Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals, preparations, and active pharmaceutical ingredients (API) products in China and internationally. The company offers clopidogrel bisulfate tablets, doxycycline hydrochloride, azithromycin, milrinone, dapoxetine hydrochloride, tadalafil, and betasine besylate tablets, as well as aprilite, danazol suppositories, and terfenadine tablets. It also provides urinary system drugs, including eprepitant tablets, terazosin tablets, and drotave... [Read more]

Sector Healthcare
Founded 1999
Employees 2,131
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600513
Full Company Profile

Financial Performance

Financial Statements